Literature DB >> 8048941

Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation.

J Quintans1, J Kilkus, C L McShan, A R Gottschalk, G Dawson.   

Abstract

We demonstrate for the first time how immature B cells kill themselves. Ceramide is identified as the mediator of apoptosis in the murine B lymphoma line WEHI 231 commonly used as a model to study clonal deletion in B lymphocytes. We show that exogenous ceramide induces apoptosis in WEHI 231 cells. To maintain self tolerance, immature lymphocytes readily undergo apoptotic death in response to the cross-linking of their antigen-specific receptors. We demonstrate that endogenously produced ceramide accumulates in WEHI 231 cells exposed to anti-IgM, an antigen surrogate before the onset of apoptosis. We also show that two other inducers of apoptosis, irradiation and dexamethasone, cause intracellular accumulation of ceramide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048941     DOI: 10.1006/bbrc.1994.1988

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  The pressure-dependence of the size of extruded vesicles.

Authors:  Philipus J Patty; Barbara J Frisken
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

2.  SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.

Authors:  Jacqueline C Shultz; Rachel W Goehe; Charuta S Murudkar; Dayanjan S Wijesinghe; Eric K Mayton; Autumn Massiello; Amy J Hawkins; Prabhat Mukerjee; Ryan L Pinkerman; Margaret A Park; Charles E Chalfant
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

3.  Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis.

Authors:  Nilank C Shah; Jian-Ping Liu; Jahangir Iqbal; Mahmood Hussain; Xian-Cheng Jiang; Zhiqiang Li; Yan Li; Tao Zheng; Wenyan Li; Anthony C Sica; Jose Luis Perez-Albela; Bella T Altura; Burton M Altura
Journal:  Int J Clin Exp Med       Date:  2011-04-05

Review 4.  Mitochondrial ceramide and the induction of apoptosis.

Authors:  Leah J Siskind
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

Review 5.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 6.  Signal transduction of stress via ceramide.

Authors:  S Mathias; L A Peña; R N Kolesnick
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

7.  Bcl-2 interrupts the ceramide-mediated pathway of cell death.

Authors:  J Zhang; N Alter; J C Reed; C Borner; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.

Authors:  Susmita Mondal; Chandan Mandal; Rajender Sangwan; Sarmila Chandra; Chitra Mandal
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

9.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

10.  Ceramide and glutathione define two independently regulated pathways of cell death initiated by p53 in Molt-4 leukaemia cells.

Authors:  Wissal El-Assaad; Lina Kozhaya; Sawsan Araysi; Shoghag Panjarian; Fadi F Bitar; Elizabeth Baz; Marwan E El-Sabban; Ghassan S Dbaibo
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.